PTK2 and breast cancer: Finally, Bernardes et al. showed that azurin attenuates invasion and FAK/Src signaling in MCF-7 breast cancer cell models with P-cadherin overexpression and can therefore probably be used therapeutically to treat poor prognosis breast cancer with P-cadherin overexpression [59].